NPS PHARMACEUTICALS INC's ticker is P103PS and the CUSIP is 62936P103. A total of 184 filers reported holding NPS PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 0.98 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $394,000 | +55.1% | 11,040 | +13.2% | 0.03% | +57.1% |
| Q3 2014 | $254,000 | -27.8% | 9,750 | -8.5% | 0.02% | -25.0% |
| Q2 2014 | $352,000 | -1.1% | 10,650 | -10.5% | 0.03% | +7.7% |
| Q1 2014 | $356,000 | -41.0% | 11,905 | -40.1% | 0.03% | -44.7% |
| Q4 2013 | $603,000 | -9.5% | 19,860 | -5.1% | 0.05% | -13.0% |
| Q3 2013 | $666,000 | +233.0% | 20,930 | +58.0% | 0.05% | +217.6% |
| Q2 2013 | $200,000 | – | 13,245 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVEY CAPITAL MANAGEMENT INC | 431,525 | $11,219,000 | 4.40% |
| Palo Alto Investors LP | 1,699,562 | $44,189,000 | 3.30% |
| FCG ADVISORS, LLC | 133,504 | $4,116,000 | 2.71% |
| SECTORAL ASSET MANAGEMENT INC | 1,726,824 | $44,897,000 | 1.89% |
| Rhenman & Partners Asset Management AB | 224,000 | $5,824,000 | 1.70% |
| BENDER ROBERT & ASSOCIATES | 75,090 | $1,952,000 | 1.36% |
| Penn Capital Management Company, LLC | 1,035,144 | $26,914,000 | 1.12% |
| NEXT CENTURY GROWTH INVESTORS LLC | 1,066,148 | $27,719,000 | 0.98% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 391,281 | $10,173,000 | 0.98% |
| SCHOLTZ & COMPANY, LLC | 31,990 | $832,000 | 0.82% |